Compiled from public manufacturer materials and regulatory sources. Not independently verified and not reviewed by a named clinician.
Topic Navigator
Topics
A topic-led view of molecular diagnostics content for disease areas, lab priorities, and buyer use cases.
Disease-ledMove from clinical scenario into content tracks.
Buyer handoffJump into product filters or RFQ from each topic.
UpdatedFreshness and FAQ count stay visible in the hero.
Topic overview
6Disease Zones
4Test Scenarios
2026-10-04Updated
Disease Zones
Respiratory
Flu/RSV/SARS-CoV-2 panels, rapid antigen, and multiplex respiratory testing.
HPV
HPV genotyping assays, cervical cancer screening, and women's health diagnostics.
STI
Sexually transmitted infection panels covering CT/NG, trichomonas, and mycoplasma.
Gastrointestinal
Gastrointestinal pathogen panels for diarrheal disease and food safety testing.
Testing Scenarios
Central Lab
High-throughput workflows for reference and central laboratories.
Browse Products →Hospital
Mid-volume testing solutions for hospital clinical labs.
Browse Products →POCT
Rapid point-of-care devices for near-patient and decentralized testing.
Browse Products →Field / Outbreak
Portable, rugged solutions for field surveillance and outbreak response.
Browse Products →Key takeaways
Topic pages group content by disease area and testing scenario so buyers can move from clinical need to technology and supplier evaluation more efficiently.
Target audienceMedical affairs teams, labs, procurement teams
Review and references
2026-10-01
2026-10-04
professional use
Navigate by disease areas: respiratory, HPV, bloodborne pathogens, STI, AMR, and outbreak response.
Latest Insights
Viral hepatitis elimination: a procurement checklist for viral-load platforms
Procurement checklist for HBV/HCV viral-load platforms in hepatitis elimination programmes: dynamic range, result discipline, supply at programme volume, and regulatory status.
NAT yield testing for mid-size blood banks: what actually drives the economics
What drives NAT yield-testing economics for mid-size blood banks: pooling strategy, yield-window claims, workflow integration, and the contract points worth verifying.
Case study: extending STI molecular testing from a referral lab into community points of care
A composite case study on decentralising STI NAAT testing to community points of care: logistics, quality controls, connectivity, and procurement scoring for the pilot.
Case study: closing an MRSA screening gap in a surgical unit
A composite case study on MRSA screening: how late reporting happens, the diagnostic decisions that close the gap, and how to verify the fix with measurable targets.